Concepts (282)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Biomedical Research | 10 | 2023 | 400 | 3.940 |
Why?
|
| Community-Institutional Relations | 8 | 2021 | 187 | 2.930 |
Why?
|
| Community-Based Participatory Research | 8 | 2023 | 317 | 2.880 |
Why?
|
| Trust | 7 | 2022 | 133 | 2.600 |
Why?
|
| Clinical Trials as Topic | 10 | 2023 | 204 | 2.440 |
Why?
|
| Minority Groups | 7 | 2022 | 596 | 2.380 |
Why?
|
| Research Subjects | 4 | 2020 | 32 | 2.200 |
Why?
|
| Research Personnel | 5 | 2022 | 155 | 2.130 |
Why?
|
| Humans | 78 | 2024 | 37093 | 1.770 |
Why?
|
| Research Design | 9 | 2022 | 313 | 1.760 |
Why?
|
| Academic Medical Centers | 2 | 2021 | 60 | 1.450 |
Why?
|
| Patient Selection | 6 | 2022 | 164 | 1.370 |
Why?
|
| United States | 22 | 2024 | 4223 | 1.310 |
Why?
|
| Patient-Centered Care | 2 | 2018 | 63 | 1.240 |
Why?
|
| Interprofessional Relations | 2 | 2018 | 54 | 1.210 |
Why?
|
| Independent Living | 2 | 2017 | 30 | 1.190 |
Why?
|
| Aged | 29 | 2024 | 6741 | 1.150 |
Why?
|
| Alzheimer Disease | 6 | 2020 | 905 | 1.140 |
Why?
|
| Osteoporosis | 4 | 2009 | 34 | 1.120 |
Why?
|
| Middle Aged | 27 | 2024 | 10129 | 1.060 |
Why?
|
| Female | 40 | 2024 | 20969 | 1.040 |
Why?
|
| Cognition Disorders | 8 | 2012 | 233 | 1.040 |
Why?
|
| Healthcare Disparities | 3 | 2020 | 494 | 1.010 |
Why?
|
| Male | 36 | 2024 | 20025 | 1.000 |
Why?
|
| Cooperative Behavior | 2 | 2017 | 219 | 0.980 |
Why?
|
| Genetic Counseling | 1 | 2024 | 11 | 0.970 |
Why?
|
| Health Status Disparities | 2 | 2020 | 642 | 0.930 |
Why?
|
| Cardiovascular System | 1 | 2023 | 33 | 0.890 |
Why?
|
| Lung Diseases | 1 | 2024 | 61 | 0.890 |
Why?
|
| Neoplasms | 3 | 2022 | 1103 | 0.880 |
Why?
|
| Community Health Services | 3 | 2022 | 185 | 0.870 |
Why?
|
| Access to Information | 2 | 2020 | 13 | 0.860 |
Why?
|
| Papillomavirus Infections | 3 | 2022 | 336 | 0.850 |
Why?
|
| Delivery of Health Care | 3 | 2021 | 276 | 0.850 |
Why?
|
| Coronary Artery Disease | 1 | 2024 | 142 | 0.850 |
Why?
|
| Comparative Effectiveness Research | 2 | 2018 | 15 | 0.820 |
Why?
|
| Skin Neoplasms | 1 | 2024 | 159 | 0.820 |
Why?
|
| Alphapapillomavirus | 1 | 2022 | 38 | 0.810 |
Why?
|
| Pilot Projects | 5 | 2022 | 661 | 0.800 |
Why?
|
| Qualitative Research | 7 | 2024 | 446 | 0.800 |
Why?
|
| Cognition | 3 | 2017 | 398 | 0.790 |
Why?
|
| Financing, Government | 1 | 2021 | 19 | 0.780 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2024 | 169 | 0.770 |
Why?
|
| Disability Evaluation | 2 | 2013 | 61 | 0.770 |
Why?
|
| Mammography | 3 | 2019 | 188 | 0.770 |
Why?
|
| Health Knowledge, Attitudes, Practice | 5 | 2022 | 864 | 0.760 |
Why?
|
| Cross-Sectional Studies | 10 | 2024 | 2721 | 0.730 |
Why?
|
| Education, Distance | 1 | 2021 | 44 | 0.730 |
Why?
|
| Attitude of Health Personnel | 3 | 2021 | 198 | 0.730 |
Why?
|
| Adult | 16 | 2024 | 11712 | 0.720 |
Why?
|
| Needs Assessment | 2 | 2018 | 170 | 0.710 |
Why?
|
| Focus Groups | 8 | 2024 | 348 | 0.710 |
Why?
|
| Schools, Medical | 1 | 2021 | 198 | 0.690 |
Why?
|
| Antipsychotic Agents | 1 | 2020 | 68 | 0.690 |
Why?
|
| Schizophrenia | 1 | 2020 | 76 | 0.690 |
Why?
|
| Vitamin D Deficiency | 4 | 2009 | 105 | 0.690 |
Why?
|
| Organizational Culture | 1 | 2018 | 14 | 0.650 |
Why?
|
| Diagnostic Imaging | 1 | 2019 | 53 | 0.650 |
Why?
|
| Group Processes | 2 | 2019 | 21 | 0.640 |
Why?
|
| Managed Care Programs | 1 | 2018 | 38 | 0.640 |
Why?
|
| Diabetes Mellitus | 1 | 2024 | 485 | 0.640 |
Why?
|
| Executive Function | 3 | 2017 | 49 | 0.640 |
Why?
|
| Social Perception | 1 | 2018 | 62 | 0.630 |
Why?
|
| Geriatric Assessment | 4 | 2013 | 51 | 0.620 |
Why?
|
| Education, Medical | 1 | 2019 | 104 | 0.620 |
Why?
|
| Health Services Research | 1 | 2018 | 148 | 0.620 |
Why?
|
| Phenotype | 1 | 2020 | 689 | 0.610 |
Why?
|
| Patient Participation | 1 | 2018 | 75 | 0.610 |
Why?
|
| Activities of Daily Living | 2 | 2009 | 105 | 0.610 |
Why?
|
| Physician-Patient Relations | 1 | 2018 | 128 | 0.600 |
Why?
|
| Health Literacy | 2 | 2019 | 105 | 0.600 |
Why?
|
| Health Education | 2 | 2020 | 338 | 0.600 |
Why?
|
| Universities | 1 | 2021 | 442 | 0.600 |
Why?
|
| Interinstitutional Relations | 1 | 2017 | 38 | 0.600 |
Why?
|
| Health Occupations | 1 | 2017 | 17 | 0.600 |
Why?
|
| Aged, 80 and over | 11 | 2024 | 2379 | 0.600 |
Why?
|
| Dementia | 2 | 2009 | 131 | 0.590 |
Why?
|
| Medically Underserved Area | 1 | 2017 | 104 | 0.580 |
Why?
|
| Cultural Competency | 2 | 2018 | 131 | 0.580 |
Why?
|
| Hypertension | 1 | 2024 | 796 | 0.570 |
Why?
|
| Physicians | 1 | 2018 | 163 | 0.550 |
Why?
|
| Awards and Prizes | 3 | 2023 | 29 | 0.550 |
Why?
|
| Asthma | 1 | 2020 | 380 | 0.550 |
Why?
|
| Tennessee | 3 | 2021 | 70 | 0.540 |
Why?
|
| Medication Therapy Management | 1 | 2015 | 9 | 0.520 |
Why?
|
| Pharmaceutical Services | 2 | 2015 | 21 | 0.520 |
Why?
|
| Interdisciplinary Communication | 1 | 2015 | 36 | 0.510 |
Why?
|
| Capacity Building | 1 | 2015 | 87 | 0.480 |
Why?
|
| Obesity | 2 | 2024 | 1067 | 0.470 |
Why?
|
| National Institutes of Health (U.S.) | 3 | 2022 | 88 | 0.460 |
Why?
|
| Program Evaluation | 1 | 2015 | 339 | 0.460 |
Why?
|
| Hypoglycemic Agents | 1 | 2015 | 160 | 0.450 |
Why?
|
| Mass Screening | 3 | 2021 | 462 | 0.430 |
Why?
|
| Young Adult | 6 | 2024 | 4268 | 0.420 |
Why?
|
| Risk Factors | 7 | 2020 | 3562 | 0.390 |
Why?
|
| Age of Onset | 3 | 2012 | 100 | 0.380 |
Why?
|
| Health Personnel | 3 | 2022 | 228 | 0.380 |
Why?
|
| Neuropsychological Tests | 6 | 2013 | 259 | 0.380 |
Why?
|
| Bone Density | 4 | 2017 | 75 | 0.360 |
Why?
|
| Bone Density Conservation Agents | 2 | 2007 | 22 | 0.360 |
Why?
|
| Reproducibility of Results | 4 | 2022 | 935 | 0.350 |
Why?
|
| Information Dissemination | 2 | 2020 | 59 | 0.350 |
Why?
|
| Decision Making | 2 | 2024 | 203 | 0.340 |
Why?
|
| Adolescent | 5 | 2024 | 5363 | 0.330 |
Why?
|
| Incidence | 3 | 2019 | 922 | 0.310 |
Why?
|
| Retrospective Studies | 5 | 2022 | 2026 | 0.310 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2015 | 643 | 0.300 |
Why?
|
| Interviews as Topic | 2 | 2019 | 381 | 0.300 |
Why?
|
| Papillomavirus Vaccines | 2 | 2022 | 151 | 0.290 |
Why?
|
| Disabled Persons | 1 | 2007 | 65 | 0.280 |
Why?
|
| Fractures, Bone | 1 | 2007 | 53 | 0.280 |
Why?
|
| Depression | 2 | 2012 | 712 | 0.280 |
Why?
|
| Mood Disorders | 1 | 2006 | 48 | 0.280 |
Why?
|
| Psychometrics | 3 | 2018 | 318 | 0.280 |
Why?
|
| Fractures, Spontaneous | 1 | 2005 | 6 | 0.270 |
Why?
|
| Health Services Accessibility | 4 | 2022 | 560 | 0.260 |
Why?
|
| Depressive Disorder, Major | 3 | 2012 | 103 | 0.250 |
Why?
|
| Case-Control Studies | 4 | 2015 | 1130 | 0.250 |
Why?
|
| Early Detection of Cancer | 3 | 2024 | 336 | 0.250 |
Why?
|
| Vitamin D | 4 | 2009 | 196 | 0.250 |
Why?
|
| Poverty | 1 | 2007 | 348 | 0.240 |
Why?
|
| Densitometry | 1 | 2004 | 13 | 0.240 |
Why?
|
| Demography | 2 | 2020 | 175 | 0.240 |
Why?
|
| Patient Preference | 1 | 2024 | 44 | 0.230 |
Why?
|
| Communication | 3 | 2023 | 180 | 0.230 |
Why?
|
| Mediastinum | 1 | 2023 | 5 | 0.230 |
Why?
|
| Cerebrovascular Disorders | 3 | 2010 | 37 | 0.230 |
Why?
|
| Sertraline | 3 | 2012 | 7 | 0.230 |
Why?
|
| Breast Neoplasms | 3 | 2019 | 1502 | 0.220 |
Why?
|
| Missouri | 2 | 2017 | 7 | 0.220 |
Why?
|
| Antidepressive Agents | 3 | 2012 | 50 | 0.220 |
Why?
|
| Aspirin | 1 | 2022 | 49 | 0.210 |
Why?
|
| Censuses | 1 | 2022 | 24 | 0.210 |
Why?
|
| Socioeconomic Factors | 2 | 2023 | 1067 | 0.200 |
Why?
|
| Heart | 1 | 2023 | 180 | 0.200 |
Why?
|
| Age Factors | 2 | 2019 | 1033 | 0.200 |
Why?
|
| Connecticut | 1 | 2021 | 14 | 0.200 |
Why?
|
| South Carolina | 1 | 2021 | 25 | 0.200 |
Why?
|
| Treatment Outcome | 4 | 2020 | 1369 | 0.190 |
Why?
|
| North Carolina | 1 | 2021 | 104 | 0.190 |
Why?
|
| Papillomaviridae | 1 | 2022 | 127 | 0.190 |
Why?
|
| Adrenergic Agonists | 1 | 2020 | 2 | 0.190 |
Why?
|
| Patient Care | 1 | 2020 | 29 | 0.190 |
Why?
|
| Chronic Disease | 1 | 2024 | 484 | 0.180 |
Why?
|
| Administration, Inhalation | 1 | 2020 | 80 | 0.180 |
Why?
|
| Schizophrenic Psychology | 1 | 2020 | 17 | 0.180 |
Why?
|
| Genomics | 1 | 2022 | 223 | 0.180 |
Why?
|
| Communication Barriers | 1 | 2020 | 56 | 0.180 |
Why?
|
| Drug Therapy, Combination | 1 | 2020 | 227 | 0.180 |
Why?
|
| Lung Neoplasms | 1 | 2024 | 358 | 0.180 |
Why?
|
| Fellowships and Scholarships | 1 | 2019 | 29 | 0.170 |
Why?
|
| Social Welfare | 1 | 2019 | 29 | 0.170 |
Why?
|
| Health Resources | 1 | 2019 | 32 | 0.170 |
Why?
|
| Cultural Diversity | 1 | 2020 | 169 | 0.170 |
Why?
|
| Faculty, Medical | 1 | 2019 | 66 | 0.170 |
Why?
|
| Social Responsibility | 1 | 2018 | 14 | 0.170 |
Why?
|
| Patient Advocacy | 1 | 2018 | 21 | 0.160 |
Why?
|
| Southeastern United States | 1 | 2018 | 49 | 0.160 |
Why?
|
| Patient Satisfaction | 1 | 2019 | 145 | 0.160 |
Why?
|
| Brain | 3 | 2012 | 1346 | 0.160 |
Why?
|
| Quality of Health Care | 1 | 2019 | 138 | 0.160 |
Why?
|
| Trail Making Test | 1 | 2017 | 3 | 0.160 |
Why?
|
| Culture | 1 | 2019 | 173 | 0.160 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2012 | 481 | 0.150 |
Why?
|
| Health Promotion | 1 | 2024 | 653 | 0.150 |
Why?
|
| Patient Education as Topic | 1 | 2019 | 215 | 0.150 |
Why?
|
| Socialization | 1 | 2017 | 19 | 0.150 |
Why?
|
| Logistic Models | 1 | 2020 | 923 | 0.150 |
Why?
|
| Educational Status | 1 | 2019 | 313 | 0.150 |
Why?
|
| Attitude to Health | 1 | 2020 | 325 | 0.150 |
Why?
|
| Comorbidity | 3 | 2009 | 623 | 0.140 |
Why?
|
| Interpersonal Relations | 1 | 2018 | 205 | 0.140 |
Why?
|
| Health Surveys | 1 | 2018 | 373 | 0.140 |
Why?
|
| Diphosphonates | 2 | 2007 | 10 | 0.140 |
Why?
|
| Parathyroid Hormone | 2 | 2007 | 37 | 0.140 |
Why?
|
| Affect | 1 | 2017 | 152 | 0.140 |
Why?
|
| Continuity of Patient Care | 1 | 2017 | 94 | 0.140 |
Why?
|
| Kidney Diseases | 1 | 2018 | 167 | 0.140 |
Why?
|
| Pharmacists | 2 | 2015 | 53 | 0.130 |
Why?
|
| Public Opinion | 1 | 2015 | 17 | 0.130 |
Why?
|
| Creatinine | 1 | 2015 | 103 | 0.130 |
Why?
|
| Feasibility Studies | 1 | 2015 | 208 | 0.130 |
Why?
|
| Smoking Cessation | 1 | 2021 | 517 | 0.120 |
Why?
|
| Proportional Hazards Models | 2 | 2013 | 441 | 0.120 |
Why?
|
| Health Status | 1 | 2017 | 380 | 0.120 |
Why?
|
| Program Development | 1 | 2015 | 233 | 0.120 |
Why?
|
| Lipids | 1 | 2015 | 235 | 0.110 |
Why?
|
| Body Mass Index | 1 | 2017 | 854 | 0.110 |
Why?
|
| Medication Adherence | 1 | 2015 | 179 | 0.110 |
Why?
|
| Leadership | 1 | 2013 | 76 | 0.110 |
Why?
|
| Personality Inventory | 1 | 2012 | 75 | 0.110 |
Why?
|
| Vascular Diseases | 1 | 2012 | 30 | 0.100 |
Why?
|
| Mental Status Schedule | 2 | 2012 | 14 | 0.100 |
Why?
|
| Longitudinal Studies | 2 | 2013 | 885 | 0.100 |
Why?
|
| Predictive Value of Tests | 1 | 2013 | 400 | 0.100 |
Why?
|
| Blood Pressure | 1 | 2015 | 646 | 0.100 |
Why?
|
| Cerebral Cortex | 1 | 2012 | 290 | 0.090 |
Why?
|
| Diagnosis, Differential | 2 | 2008 | 217 | 0.090 |
Why?
|
| Psychology | 1 | 2009 | 36 | 0.080 |
Why?
|
| Task Performance and Analysis | 1 | 2009 | 37 | 0.080 |
Why?
|
| Femur | 1 | 2009 | 36 | 0.080 |
Why?
|
| Lumbar Vertebrae | 1 | 2009 | 31 | 0.080 |
Why?
|
| Probability | 1 | 2009 | 78 | 0.080 |
Why?
|
| ROC Curve | 1 | 2009 | 138 | 0.080 |
Why?
|
| Physical Fitness | 1 | 2009 | 90 | 0.080 |
Why?
|
| Time Factors | 1 | 2013 | 1742 | 0.080 |
Why?
|
| Follow-Up Studies | 2 | 2017 | 974 | 0.080 |
Why?
|
| Nutritional Status | 1 | 2009 | 116 | 0.080 |
Why?
|
| Likelihood Functions | 1 | 2007 | 59 | 0.080 |
Why?
|
| Patient Care Team | 1 | 2007 | 47 | 0.070 |
Why?
|
| Bone Remodeling | 1 | 2007 | 9 | 0.070 |
Why?
|
| Calcitonin | 1 | 2007 | 5 | 0.070 |
Why?
|
| Cohort Studies | 2 | 2022 | 1492 | 0.070 |
Why?
|
| Medical History Taking | 1 | 2006 | 33 | 0.070 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2007 | 44 | 0.070 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2007 | 32 | 0.070 |
Why?
|
| Hippocampus | 2 | 2012 | 561 | 0.070 |
Why?
|
| Parents | 2 | 2022 | 329 | 0.070 |
Why?
|
| Institutionalization | 1 | 2005 | 1 | 0.070 |
Why?
|
| Spinal Fractures | 1 | 2005 | 3 | 0.070 |
Why?
|
| Cerebral Amyloid Angiopathy | 1 | 2006 | 17 | 0.070 |
Why?
|
| Lewy Bodies | 1 | 2006 | 30 | 0.070 |
Why?
|
| Social Environment | 1 | 2007 | 207 | 0.070 |
Why?
|
| Accidental Falls | 1 | 2005 | 26 | 0.070 |
Why?
|
| Hip Fractures | 1 | 2005 | 23 | 0.070 |
Why?
|
| Neurofibrillary Tangles | 1 | 2006 | 113 | 0.070 |
Why?
|
| Weight Loss | 1 | 2006 | 131 | 0.070 |
Why?
|
| Exercise Therapy | 1 | 2005 | 69 | 0.060 |
Why?
|
| Ketanserin | 1 | 2004 | 4 | 0.060 |
Why?
|
| Receptor, Serotonin, 5-HT2A | 1 | 2004 | 16 | 0.060 |
Why?
|
| Primary Health Care | 1 | 2007 | 294 | 0.060 |
Why?
|
| Positron-Emission Tomography | 1 | 2004 | 80 | 0.060 |
Why?
|
| Patient Compliance | 1 | 2005 | 212 | 0.060 |
Why?
|
| Motor Activity | 1 | 2006 | 418 | 0.060 |
Why?
|
| Risk Assessment | 1 | 2007 | 753 | 0.060 |
Why?
|
| Age Distribution | 1 | 2004 | 225 | 0.060 |
Why?
|
| Algorithms | 2 | 2022 | 465 | 0.060 |
Why?
|
| Depressive Disorder | 1 | 2004 | 174 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2024 | 214 | 0.050 |
Why?
|
| Calcium | 1 | 2005 | 480 | 0.050 |
Why?
|
| Ecosystem | 1 | 2023 | 123 | 0.050 |
Why?
|
| Research Support as Topic | 1 | 2022 | 80 | 0.050 |
Why?
|
| Electronic Health Records | 1 | 2022 | 66 | 0.050 |
Why?
|
| Prevalence | 1 | 2005 | 1455 | 0.050 |
Why?
|
| Linear Models | 2 | 2015 | 275 | 0.050 |
Why?
|
| Vaccination | 1 | 2022 | 288 | 0.050 |
Why?
|
| Publications | 1 | 2020 | 7 | 0.050 |
Why?
|
| Latin America | 1 | 2020 | 45 | 0.050 |
Why?
|
| Neural Pathways | 2 | 2012 | 124 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2020 | 268 | 0.040 |
Why?
|
| Severity of Illness Index | 2 | 2012 | 610 | 0.040 |
Why?
|
| Cultural Characteristics | 1 | 2019 | 125 | 0.040 |
Why?
|
| Electronic Mail | 1 | 2017 | 2 | 0.040 |
Why?
|
| Telephone | 1 | 2017 | 34 | 0.040 |
Why?
|
| Urination Disorders | 1 | 2017 | 3 | 0.040 |
Why?
|
| Religion | 1 | 2018 | 87 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2012 | 1378 | 0.040 |
Why?
|
| Discriminant Analysis | 1 | 2015 | 23 | 0.030 |
Why?
|
| Brain Mapping | 2 | 2008 | 112 | 0.030 |
Why?
|
| Registries | 1 | 2017 | 335 | 0.030 |
Why?
|
| Emotions | 1 | 2018 | 220 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2015 | 455 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2015 | 286 | 0.030 |
Why?
|
| Smoking | 1 | 2021 | 940 | 0.030 |
Why?
|
| Motivation | 1 | 2018 | 436 | 0.030 |
Why?
|
| Parahippocampal Gyrus | 1 | 2012 | 1 | 0.030 |
Why?
|
| Caudate Nucleus | 1 | 2012 | 20 | 0.030 |
Why?
|
| Frontal Lobe | 1 | 2012 | 48 | 0.030 |
Why?
|
| Organ Size | 1 | 2012 | 157 | 0.030 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2012 | 61 | 0.030 |
Why?
|
| Reaction Time | 1 | 2012 | 143 | 0.030 |
Why?
|
| Amygdala | 1 | 2012 | 114 | 0.030 |
Why?
|
| Memory | 1 | 2012 | 170 | 0.020 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2010 | 253 | 0.020 |
Why?
|
| Child | 1 | 2015 | 3131 | 0.020 |
Why?
|
| Physical Examination | 1 | 2006 | 43 | 0.020 |
Why?
|
| Fluorine Radioisotopes | 1 | 2004 | 11 | 0.020 |
Why?
|
| Body Weight | 1 | 2006 | 434 | 0.010 |
Why?
|
| Aging | 1 | 2006 | 664 | 0.010 |
Why?
|
| Protein Binding | 1 | 2004 | 972 | 0.010 |
Why?
|
| Pharmacies | 1 | 1954 | 21 | 0.010 |
Why?
|
| Pharmacy | 1 | 1954 | 30 | 0.010 |
Why?
|